Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Enzymatic Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN115109769A reveals T202S/T202G mutants enabling >99% conversion at high formaldehyde concentrations for efficient L-serine production.
Enzymatic synthesis patent CN104630297B offers high-purity Rosuvastatin intermediate with reduced cost and scalable supply chain reliability for global buyers.
Patent CN113025679B details a green enzymatic route for cefcapene precursor acid, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturers.
Patent CN108239019A enables enzymatic synthesis of chiral piperidine esters. Offers cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Novel enzymatic synthesis route for high-purity SOS1 inhibitor intermediate. Reduces steps, avoids hazardous reagents, ensures scalable supply chain reliability for global pharma partners.
Patent CN115448912B reveals high-purity posaconazole intermediate synthesis. Enzymatic route offers supply chain stability and cost reduction in API manufacturing.
Patent CN115011661B reveals enzymatic synthesis for 3 beta-ursodeoxycholic acid. High purity, mild conditions, scalable supply chain solutions for pharma.
Patent CN112680497A reveals enzymatic splitting for high-purity Corey lactone. Achieve significant cost reduction in API intermediate manufacturing and supply reliability.
Novel 4-step enzymatic route for Ritlecitinib Tosylate. Eliminates metal catalysts and chiral columns. High purity, scalable supply for global pharma partners.